Anthi Petrou
Thessaloniki, ESYE12 54124, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Corrigendum to "Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies" [Int. J. Biol. Macromol. Volume 260 (2024), 129308].
Journal: International journal of biological macromolecules
Published: July 15, 2026
p-Aminobenzene-Sulfonamide Derivatives of Substituted Pyrimidines as Human Carbonic Anhydrase Inhibitors.
Journal: International journal of molecular sciences
Published: February 18, 2026
Synthesis, neurotropic activity and docking studies of 1,2,4-triazole-linked hybrids based on 2,7-naphthyridine and bispidine rings.
Journal: RSC advances
Published: January 12, 2026
Thiazolidinsone derivatives bearing sulfonamide group as potential antimicrobial agents: biological and in silico evaluation.
Journal: SAR and QSAR in environmental research
Published: November 07, 2025
Investigating Amphoteric 3,4'-Biscoumarin-Based ortho-[(Dialkylamino)methyl]phenols as Dual MAO and ChE Inhibitors.
Journal: International journal of molecular sciences
Published: August 01, 2025
Design, Synthesis, and In Vitro and In Silico Study of New Hybrid 1-(2-(4-Arylthiazol-2-yl)hydrazineylidene)-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2-ones as Factor Xa and Factor XIa Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: July 14, 2025
Coumarin-Containing Aromatic Sulfonamides With Carbonic Anhydrase Inhibitory Properties Against Human and Fungal Isoforms.
Journal: Chemical biology & drug design
Published: May 26, 2025
Synthesis and Neurotropic Activity of New 5-Piperazinopyrazolo[3,4-c]-2,7-naphthyridines and Isoxazolo[5,4-c]-2,7-naphthyridines.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 25, 2025
Rational Design, Synthesis, and Biological Evaluation of Novel Thiazole/Thiazolidinones Multitarget Anti-Human Immunodeficiency Virus Molecules.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 15, 2025
Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type II.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 17, 2024
Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: An unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler.
Journal: European journal of medicinal chemistry
Published: September 23, 2024
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches.
Journal: International journal of molecular sciences
Published: July 22, 2024
Last Updated: 09/26/2026